Keywords: ustekinumab, gold, standard, psoriasis, following, its, approval
Ustekinumab: "gold standard" for psoriasis by 2011
Article | 18 February 2008
Following its approval in early 2009, Centocor/Janssen-Cilag's ustekinumab will become the clinical gold standard for psoriasis by 2011, says a new ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
